Inventor · disambiguated record
Thomas A. Davis
Also filed as: DAVIS THOMAS · DAVIS THOMAS A · DAVIS THOMAS ANDREW
11 granted patents·11 pending applications·244 citations·filing 1993–2025
91Inventor score
Top patents by PatentIndex Score
22 records- 0196US7452535B2Methods of treatment using CTLA-4 antibodiesMEDAREX INC·Filed 2003·Granted Nov 18, 2008·70 cites·18 claims
- 0294US10668152B2Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatmentBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jun 2, 2020·7 cites·21 claims
- 0393US10392442B2Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatmentBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Aug 27, 2019·6 cites·20 claims
- 0493US8142778B2Methods of treatment using CTLA-4 antibodiesDAVIS THOMAS ANDREW·Filed 2008·Granted Mar 27, 2012·25 cites·75 claims
- 0587US11965031B2Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatmentBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Apr 23, 2024·1 cites·18 claims
- 0687US2024360235A1Use of anti-pd-1 antibody in combination with anti-cd27 antibody in cancer treatmentBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 0786US8510245B2Bayesian clinical decision model for determining probability of transplant glomerulopathySTOJADINOVIC ALEXANDER·Filed 2011·Granted Aug 13, 2013·12 cites·7 claims
- 0882US5599703AIn vitro amplification/expansion of CD34+ stem and progenitor cellsUS NAVY·Filed 1993·Granted Feb 4, 1997·78 cites·9 claims
- 0980US10726943B2Clinical decision modelSTOJADINOVIC ALEXANDER·Filed 2011·Granted Jul 28, 2020·2 cites·10 claims
- 1076US2025154274A1Use of anti-pd-1 antibody in combination with anti-cd27 antibody in cancer treatmentBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 1171US2020024355A1Use of anti-pd-1 antibody in combination with anti-cd27 antibody in cancer treatmentBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 1269US2020335179A1Clinical decision modelUS NAVY·Filed 2020·Application pending·0 cites
- 1368US2011295782A1Clinical Decision ModelSTOJADINOVIC ALEXANDER·Filed 2009·Application pending·0 cites
- 1467US6642049B1Human brain endothelial cells and growth medium and method for expansion of primitive CD34+CD38-bone marrow stem cellsUS NAVY·Filed 1999·Granted Nov 4, 2003·27 cites·15 claims
- 1559US6572867B1Inhibition of xenoreactive antibodiesBAXTER INT·Filed 1999·Granted Jun 3, 2003·16 cites·7 claims
- 1659US2004141944A1Inhibition of xenoreactive antibodiesFiled 2003·Application pending·0 cites
- 1758US2008124396A1Inhibition of Xenoreactive AntibodiesMAYO FOUNDATION·Filed 2007·Application pending·0 cites
- 1849US2011091426A1Human brain endothelial cells and growth medium and method for expansion of primitive CD34+CD38- bone marrow stem cellsCHUTE JOHN P·Filed 2003·Application pending·0 cites
- 1948US2003124091A1Endothelial cell derived hematopoietic growth factorLARGE SCALE BIOLOGY CORP·Filed 2002·Application pending·0 cites
- 2040US2004151700A1Ex-vivo rescue of transplantable hematopoietic stem cells following myeloablative injuryFiled 2002·Application pending·0 cites
- 2139US9457052B2Allograft tolerance inductionDAVIS THOMAS A·Filed 2014·Granted Oct 4, 2016·0 cites·10 claims
- 2230US2012076776A1Method for treating inflamation by lymphocyte depletion or sequesteringELSTER ERIC·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas A. Davis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →